Allotment is out. Check your result on the Accretion Nutraveda SME IPO Allotment Status page.
Accretion Nutraveda SME logo

Accretion Nutraveda SME IPO Subscription Status

|Alloted

Accretion Nutraveda SME IPO closed on 30 January 2026 with an overall subscription of 1.91x based on shares applied. QIB demand came in at 1.01x, NII at 2.42x, and retail at 2.19x.

Allotment will be finalised on 2 February 2026. The stock is scheduled to list on NSE and BSE on 4 February 2026.

Issue Price

Rs 129.00

GMP Today

Rs 68.00 (+52.71%)

Overall Subscription

1.91x

Issue Size

₹23.53 Cr

Allotment Date

2 Feb 2026

Listing Date

4 Feb 2026

Accretion Nutraveda SME IPO Subscription by Amount

Category-wise subscription based on amount applied at issue price Rs 129.00

CategoryAmount OfferedAmount AppliedSubscription
QIBRs 4.70 CrRs 4.73 Cr1.01x
FII-Rs 4.67 Cr-
DFI---
Mutual Funds---
Other-Rs 6.45 L-
NIIRs 3.56 CrRs 8.63 Cr2.42x
bNII (above Rs 10L)Rs 2.37 CrRs 5.87 Cr2.47x
Corporate-Rs 1.44 Cr-
Individual-Rs 4.32 Cr-
Other-Rs 10.32 L-
sNII (Rs 2L to Rs 10L)Rs 1.19 CrRs 2.76 Cr2.33x
Corporate-Rs 3.87 L-
Individual-Rs 2.64 Cr-
Other-Rs 7.74 L-
INDRs 8.26 CrRs 18.11 Cr2.19x
Fixed price-Rs 18.11 Cr-
TotalRs 16.51 CrRs 31.48 Cr1.91x

Accretion Nutraveda SME IPO Subscription by Applications

Category-wise subscription based on applications received

CategoryApplications OfferedApplications ReceivedSubscription
QIB36420.01x
FII-1-
DFI---
Mutual Funds---
Other-1-
NII921071.16x
bNII (above Rs 10L)61450.74x
Corporate-3-
Individual-41-
Other-1-
sNII (Rs 2L to Rs 10L)31622.00x
Corporate-1-
Individual-59-
Other-2-
IND3207022.19x
Fixed price-702-
Total7768111.05x

What Do These Subscription Numbers Mean?

A subscription of 1.91x by shares means the IPO received bids for 2 times the shares reserved. Allotment odds depend on application count in each category, not share volume.

Here is what each category number tells you:

QIB at 1.01x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 1.01x, it reflects serious institutional conviction.

NII at 1.16x by applications: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription. bNII came in at 0.74x and sNII at 2.00x by applications. Share subscription was 2.42x. Allotment uses application count, not share volume.

At 2.19x subscription by applications, approximately 1 in 2 retail applicants can expect an allotment (~46% per application). Retail allotment is done by lottery when oversubscribed.

Accretion Nutraveda SME IPO Allotment Chances

Allotment odds below use application subscription (number of bids received), not share or amount subscribed.

Retail (IND)

  • Application subscription: 2.19x.
  • Allotment odds: about 1 in 2 (~46% chance per application).
  • Method: Lottery. If allotted, you receive at least one lot.
  • One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.

SHNI (Rs 2 lakh to Rs 10 lakh)

  • Application subscription: 2.00x.
  • Allotment odds: about 1 in 2 for a minimum-lot application (~50% of the applied lot on average).
  • Method: Proportional. Shares allotted are based on your bid size, not a lottery.

BHNI (above Rs 10 lakh)

  • Application subscription: 0.74x.
  • Share subscription was 2.47x. Allotment uses application count, not share volume.

Check the Accretion Nutraveda SME IPO Allotment Status page from 2 February 2026 for your allotment result.

Accretion Nutraveda SME IPO GMP After Subscription

GMP for Accretion Nutraveda SME stands at Rs 68.00 today, giving an estimated listing price of Rs 197.00 per share.

A subscription of 1.91x combined with a GMP of 52.71% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.

Track live GMP on the Accretion Nutraveda SME IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.

Accretion Nutraveda SME IPO Day-wise Subscription

DayQIBNIIRetailOverall
Day 1 - 28 Jan 20260.00x0.45x0.21x0.20x
Day 2 - 29 Jan 20260.99x0.64x0.43x0.64x
Day 3 - 30 Jan 20261.01x2.08x2.19x1.83x

Accretion Nutraveda SME IPO Key Dates

EventDate
IPO Open Date28 January 2026
IPO Close Date30 January 2026
Allotment Date2 February 2026
Refund Initiation3 February 2026
Share Credit to Demat3 February 2026
Listing Date4 February 2026
Minimum InvestmentRs 2,58,000.00
Lot Size1000 shares

About Accretion Nutraveda SME

No company information available

Understanding Subscription Categories

QIB - Qualified Institutional Buyers

Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.

NII - Non-Institutional Investors

High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.

IND - Individual Investors

Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.

Advertisement

Accretion Nutraveda SME IPO Subscription FAQs

What is Accretion Nutraveda SME IPO subscription status today?

Accretion Nutraveda SME IPO subscription closed on 30 January 2026 with overall subscription of 1.91x (by shares) as of 27 June 2026, 3:17 AM IST. QIB 1.01x, NII 1.16x, IND 2.19x.

What is the overall subscription of Accretion Nutraveda SME IPO?

Accretion Nutraveda SME IPO is subscribed 1.91x overall by shares at close on 30 January 2026. QIB 1.01x, NII 1.16x, and IND 2.19x.

What is Accretion Nutraveda SME IPO QIB subscription?

Accretion Nutraveda SME IPO QIB (Qualified Institutional Buyers) subscription is 1.01x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.

What is Accretion Nutraveda SME IPO IND subscription?

Accretion Nutraveda SME IPO IND subscription is 2.19x by applications. Minimum retail bid is up to Rs 2 lakh per PAN.

What is Accretion Nutraveda SME IPO NII subscription?

Accretion Nutraveda SME IPO NII (Non-Institutional Investors) subscription is 1.16x by applications. NII covers bids above Rs 2 lakh.

What are allotment chances in Accretion Nutraveda SME IPO for retail?

At 2.19x subscription by applications, approximately 1 in 2 retail applicants can expect an allotment (~46% per application). Allotment is done by lottery.

When is Accretion Nutraveda SME IPO allotment date?

Accretion Nutraveda SME IPO allotment date is 2 February 2026. Check Accretion Nutraveda SME IPO Allotment Status on IPOwiz from that day using your PAN.

When does Accretion Nutraveda SME IPO subscription close?

Accretion Nutraveda SME IPO subscription closed on 30 January 2026. No new applications are accepted after the close.

What is Accretion Nutraveda SME IPO GMP today?

Accretion Nutraveda SME IPO GMP is ₹68 today (+52.71% over issue price ₹129). See live GMP on the Accretion Nutraveda SME IPO GMP Today page.

What is Accretion Nutraveda SME IPO issue price and lot size?

Accretion Nutraveda SME IPO issue price is ₹129 per share. Lot size is 1000 shares. Minimum investment is ₹2,58,000 per lot (minimum 2 lots for SME). Issue size: ₹23.53 Cr.

When is Accretion Nutraveda SME IPO listing date?

Accretion Nutraveda SME IPO listing date is 4 February 2026 on NSE and BSE. Allotment is on 2 February 2026.

How does subscription affect Accretion Nutraveda SME IPO allotment?

Allotment odds in Accretion Nutraveda SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII proportional allotment at 1.16x by applications means roughly 1 in 1 for minimum-lot bids. At 1.91x overall, competition is moderate.

For allotment results from 2 February 2026, visit the Accretion Nutraveda SME IPO Allotment Status page. For listing day updates on 4 February 2026, download the IPOwiz App.

Reviewed by Dinesh Agrawal

15+ years in Indian capital markets and IPO research. Subscription data verified before publish.